Blinding Reviewers to Authors’ Identity, Detecting Duplicate Publication, and Blacklisting Authors
September 4, 2007 to September 8, 2007
Recently, we received a manuscript for consideration and, upon checking, the reviewer was able to determine that the authors had previously published a substantial amount of the work in another PubMed-listed journal, despite the authors stating that it had not previously been published. Needless to say, we rejected the manuscript and have banned the authors from ever publishing in our journal in the future.
This brings up the point of should we have a "blacklist" of authors
for other WAME members to be able to access. Not, in my opinion, for those
authors to be automatically be excluded from all journals, but for other editors
to be aware that these authors may choose their journal for their article which
has been rejected by the other journal (because of previous publication). I
believe that if we had blinded the authors from the reviewer, that we possibly
would have failed to detect the attempt at duplicate publication. If we had
accepted their article and subsequently discovered that it had previously been
published, we would then have to go through the lengthy process of notifying
our readers and the editor of the other journal, plus the authors' institution,
of the duplicate publication. I believe it is better to try and stop this
practice rather than having the ambulance at the bottom of the cliff. What are
the opinions of the WAME members?
Rob Siebers
Editor, New Zealand Journal of Medical
Laboratory Science
______________________________
The suggestion of blacklisting authors who have done
egregious things has come up before. I would vote strongly against this.
Although I find it revolting that people would do such things, being placed on
a blacklist could be fatal to one’s career. If we were to do this, then each
and every instance of alleged attempted duplication of publication or
fabrication of data or other type of fraud, such as that described by Rob above,
would have to be formally investigated with a rigorous “due process.” Otherwise,
serious and harmful mistakes could be made. And even if mistakes were not made,
the consequences of such an action would be so dire that we could expect
lawsuits for publishing someone’s name on such a list. Also, there are lots of
grey areas. The surgical literature contains many papers where very prominent
surgeons have regularly “updated” (ie, republished after adding a few more
cases) the results of their series of cases of a specific procedure for a
specific condition. In my mind, this is duplicate publication.
Rob’s diligence is the only way for us to guard against this
type of fraud. It is clearly his right to prevent such an author (or team of
authors) from publishing in his journal again, and we have done the same. But
that can be done internally among the journal staff. An additional step they
might take would be to present the evidence of attempted duplication of
publication to the authors’ institution(s) and let them decide if some
punishment is in order. When they behave badly, such authors cast a shadow on
the reputation of their institutions. If I were a Dean, I would carefully
investigate such allegations and severely punish those found guilty.
Bill Tierney
______________________________
Rob Siebers, I only second your views.
I strongly feel that blinding the review process is to be discouraged. I go a step ahead and would say that even the identity of reviewers should be revealed (as a sign of respect for their work and for holding them responsible for what they allow to be published) at the end of each paper. At the end of every year, the journal may also publish the list of papers rejected by them with indications of reasons.
I understand that there may be practical problems which is why many journals are not practicing it.
V Raveenthiran
Associate Editor, Indian
Journal of Surgery
______________________________
The journal I previously worked on initially masked authors’
identities, then gave up because it was just too much work. We found no change
in the kinds of reviews we received. Also, I believe some studies have
been done of this that indicate masking does not improve the fairness of
review—it just makes people FEEL it is fairer.
I think the benefits—as Mr Siebers outlines them—outweigh the risks. Also, it is nearly impossible to completely mask a paper without going to ridiculous lengths.
Lisa Dittrich
Director of Publications, ASBMR Publications
______________________________
I agree entirely with Lisa…and it is interesting that,
although we offer masking as an option, in my 13 years as editor of Injury Prevention, I can only recall a
handful...perhaps about 6 papers...where this was requested. The evidence
suggests it makes little difference, but it may make some authors feel better.
IB Pless
Editor, Injury
Prevention
______________________________
It is a shame that although many journals already warn about
the seriousness of duplicate publication, some authors continue to take a
chance. The same goes for disclosing conflicts of interest. Of course, some
offending authors may be novices or may have made a mistake, and this needs to
be investigated too before any blacklisting. I think the peer review process needs to be seen
more as a team effort to ensure the quality of the scientific literature than a
black box. Authors need to know that journals’ policies are there to protect
not only the journal, the scientific archive and process, and the public, but
also, by default, the authors’ reputation. Perhaps if open review is framed
that way, everyone can be on the same page to achieve objectivity and
transparency.
From my experience, editorial offices are too busy to do manuscript masking properly, let alone do Web or non-Web searches to check for duplicate publication or plagiarism. Also, masking is difficult (self-identifiers can appear in any section of the paper, references, photos/figures, meta-data), and reviewers who know the literature well can guess. Why not take advantage of that expertise, make open peer review or at least single-masked review the norm, and routinely encourage reviewers to help out as the ethics police?
After all, the usual requests to reviewers are to check for scientific integrity, originality, quality, usefulness, etc. Detecting duplicate publication and plagiarism, which undermine those items, would make the checking more thorough. Add to that any ethical problems in the paper missed by the editorial office, as well as possible conflicts of interest that the reviewer may know the author has, which may have clouded the objectivity of reporting. In fact, disclosures of conflicts should really be forwarded to the reviewers too, again to reap the benefit of another fresh set of eyes in judging the quality of the paper. A standardised mini-CV (conflictionis vitae; http://www.bmj.com/cgi/eletters/332/7555/1444?ehom#136275) could be designed for this purpose, and it should include all possible financial and non-financial conflicts of interest, as well as financial ones of family members and employer.
For journals opting to use open review, to be truly open, the articles should include the names of reviewers, with their brief statement of relevant conflicts of interest. It should be made clear to everyone, though, that the decision to publish is ultimately the Editor’s (or a proxy if the Editor is an author).
Trevor Lane
______________________________
We have found that the masking of authors and reviewers
within a peer review process has been beneficial when an extensive degree of
opinion is incorporated into results/conclusions, such as in clinical practice
guidelines. Occasionally, a reviewer's perception of the perspective an author
'is coming from' has appeared to undermine the reviewer's objectiveness.
Perhaps the impact of masking relates to the type of peer-reviewed piece?
Thor Eglington
Editor-in-chief, The
CCA•CFCREAB-CPG

